Evidence map›Paper›PMID 31636633›Full record

ArticleFrontiers in immunology2019

Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1.

Bergeline C Nguemwo Tentokam, Chanaki Amaratunga, Nada A H Alani, Nicholas J MacDonald, David L Narum, Nichole D Salinas, Jennifer L Kwan, Seila Suon, Sokunthea Sreng, Dhelio Batista Pereira and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Evaluation of the transmission-blocking potential ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in immunology · 2022
    Review
  9. Article
  10. Progress towards the development of aExpert review of vaccines · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Bergeline C Nguemwo TentokamLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Chanaki AmaratungaLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Rockville, MD, United States.
Nada A H AlaniLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Nicholas J MacDonaldLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
David L NarumLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Nichole D SalinasLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Jennifer L KwanLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Seila SuonNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Sokunthea SrengNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Dhelio Batista PereiraCentro de Pesquisa em Medicina Tropical, Porto Velho, Brazil.
Niraj H ToliaLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Ricardo T FujiwaraDepartment of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Lilian L BuenoDepartment of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Patrick E DuffyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Camila H CoelhoLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USCambodia National Malaria Center · KHUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overAge FactorsAntibodies, ProtozoanAntigens, ProtozoanFemaleHemoglobinsHumansImmunoglobulin GMalaria VaccinesMalaria, VivaxMaleMiddle AgedPlasmodium falciparumPlasmodium vivaxAntibodies, ProtozoanAntigens, ProtozoanHemoglobinsImmunoglobulin GMalaria VaccinesmalariaPlasmodium vivaxPvs230seroreactivitytransmission-blocking vaccine

Identifiers

PMID31636633
PMCPMC6788386
OpenAlexW2977469281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.